Small Molecule Therapeutics Scientific Interest Group
The Small Molecule Therapeutics SIG aims to have discussions, seminars and provide a platform for collaboration on interdisciplinary research that results in the identification of potent, safe, and pharmacokinetically desirable chemical entities as therapeutics against different disease areas. Discovery of small molecule therapeutics (molecular weight less than 750 Daltons) involves collaboration from scientists with expertise in target (protein) identification and validation, assay development, screening, lead molecule identification and optimization. Scientists with expertise in biology, medicinal chemistry, structural biology, cheminformatics, and computational chemistry (to name a few) are involved in this endeavor.
Mailing List
To join the Small Molecule Therapeutics Scientific Interest Group mailing list, please visit the Small Molecule Therapeutics Scientific Interest Group Listserv home page, then click the “Subscribe or Unsubscribe” link in the right sidebar.
Chair
- Debananda Das, Ph.D., NCI
Advisors
Scientific Focus Areas
This page was last updated on Tuesday, June 11, 2024